Loading stock analysis…
Evidence Synthesis
Last synthesized: 11 Jul 2026, 12:19
Narrative updating · score is newerEvidence Synthesis
TMCV's 32.35% accelerated, up from 8.49% on 2026-07-10, marking a significant shift in its financial health.
The company's also accelerated, up from on the same date, indicating a substantial improvement in its operational efficiency. However, its decelerated, down from on the same date, suggesting a decline in revenue growth.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 32.35 % | 8.49 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 8.49 % | 3.61 | ▲ |
| REVENUE_GROWTH_YOY | -37.8 % | -25.3 | ▼ |
| EPS_ACTUAL | 5.303 INR | 6.08 | ▼ |
| EPS_SURPRISE_PERCENT | 0.187 % | 0.169 | ▲ |
| PRICE_CHANGE_PERCENT | 0.744 % | — | - |
| DAILY_VOLUME | 52,97,263 shares | 96,07,227 | ▼ |
| CLOSE_PRICE | 419.85 INR | 416.75 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.81 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 5 count | 12 | ▼ |
| TARGET_PRICE_PREMIUM | 14.53 % | — | - |